BRPI0803092A2 - sìntese de (s)-(+)-3-(aminometil)-5-metil ácido hexanóico, (s)-pregabalina - Google Patents

sìntese de (s)-(+)-3-(aminometil)-5-metil ácido hexanóico, (s)-pregabalina Download PDF

Info

Publication number
BRPI0803092A2
BRPI0803092A2 BRPI0803092-8A BRPI0803092A BRPI0803092A2 BR PI0803092 A2 BRPI0803092 A2 BR PI0803092A2 BR PI0803092 A BRPI0803092 A BR PI0803092A BR PI0803092 A2 BRPI0803092 A2 BR PI0803092A2
Authority
BR
Brazil
Prior art keywords
aminomethyl
synthesis
pregabalin
hexanoic acid
methyl hexanoic
Prior art date
Application number
BRPI0803092-8A
Other languages
English (en)
Inventor
Vinod Kumar Kansal
Brijnath P Chaurasia
Anand Prakash Tiwari
Shivaji Haribhau Shelke
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of BRPI0803092A2 publication Critical patent/BRPI0803092A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/07—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/26—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon starting from organic compounds containing only halogen atoms as hetero-atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/10—Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2529/00—Catalysts comprising molecular sieves
    • C07C2529/04—Catalysts comprising molecular sieves having base-exchange properties, e.g. crystalline zeolites, pillared clays
    • C07C2529/06—Crystalline aluminosilicate zeolites; Isomorphous compounds thereof
    • C07C2529/40—Crystalline aluminosilicate zeolites; Isomorphous compounds thereof of the pentasil type, e.g. types ZSM-5, ZSM-8 or ZSM-11

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SìNTESE DE (S)-(+)-3-(AMINOMETIL)-5-METIL áCIDO HEXANóICO, (S)-PREGABALINA. A invenção abrange a síntese de (S)-(+)-3-(aminometil)-5-ácido metilhexanóico, (S)-pregabalina, via um quiral intermediário da seguinte fórmula 4 em que Ar é um grupo aromático C~6-10~, R é um alquil, éster, ou ácido carboxilico C~1-4~ direto ou ramificado, e R~1~ é um alquil, araiquil, ou aralquil substituído C~1-5~ direto ou ramificado.
BRPI0803092-8A 2007-03-22 2008-03-24 sìntese de (s)-(+)-3-(aminometil)-5-metil ácido hexanóico, (s)-pregabalina BRPI0803092A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91957507P 2007-03-22 2007-03-22
US93231707P 2007-05-29 2007-05-29
PCT/US2008/003898 WO2008118427A2 (en) 2007-03-22 2008-03-24 Synthesis of (s)-(+)-3-(aminomethyl)-5-methyl hexanoic acid

Publications (1)

Publication Number Publication Date
BRPI0803092A2 true BRPI0803092A2 (pt) 2011-08-30

Family

ID=39567149

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0803092-8A BRPI0803092A2 (pt) 2007-03-22 2008-03-24 sìntese de (s)-(+)-3-(aminometil)-5-metil ácido hexanóico, (s)-pregabalina

Country Status (8)

Country Link
US (1) US8097754B2 (pt)
EP (1) EP2021318A2 (pt)
KR (1) KR101036536B1 (pt)
BR (1) BRPI0803092A2 (pt)
CA (1) CA2681313C (pt)
MX (1) MX2008014759A (pt)
TW (1) TW200846308A (pt)
WO (1) WO2008118427A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2619472A1 (en) 2005-09-19 2007-03-29 Teva Pharmaceutical Industries Ltd. Chiral 3-carbamoylmethyl-5-methyl hexanoic acids, key intermediates for the new synthesis of (s)-pregabalin
KR101036536B1 (ko) 2007-03-22 2011-05-24 테바 파마슈티컬 인더스트리즈 리미티드 (ｓ)-(+)-3-(아미노메틸)-5-메틸 헥산산의 합성
US20110245536A1 (en) * 2008-06-02 2011-10-06 Actavis Group Ptc Ehf Process for preparing pregabalin
WO2011086565A1 (en) * 2010-01-15 2011-07-21 Lupin Limited Method for preparation of enantiomerically enriched and/or racemic gamma-amino acids
JP6482465B2 (ja) 2012-11-07 2019-03-13 ハイカル リミテッド プレガバリンの調製方法
WO2017019791A1 (en) 2015-07-27 2017-02-02 Teva Pharmaceuticals International Gmbh Synthesis of (s)-pregabalin
BR112018070480A2 (pt) * 2016-04-06 2019-01-29 Rhodia Operations composto da fórmula, processo para fabricar o composto da fórmula, mistura, uso do composto da fórmula, e, composição em gel
CN108456143A (zh) * 2017-02-22 2018-08-28 尚科生物医药（上海）有限公司 不对称制备(s)-3-氨甲基-5-甲基己酸
EP3466398A1 (en) 2017-10-05 2019-04-10 Rhodia Operations N-hydrocarbyldiamide composition with gelating properties
CN116554062A (zh) * 2021-10-08 2023-08-08 浙江华海药业股份有限公司 一种普瑞巴林中间体杂质化合物ii及其制备方法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2053582T3 (es) 1986-08-13 1994-08-01 Ciba Geigy Ag Procedimiento para la obtencion de derivados del acido 5-amino-4-hidroxivalerianico.
US6197819B1 (en) 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
US5616793A (en) 1995-06-02 1997-04-01 Warner-Lambert Company Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid
US5637767A (en) 1995-06-07 1997-06-10 Warner-Lambert Company Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid
DE19530637A1 (de) 1995-08-21 1997-02-27 Bayer Ag Verfahren zur Herstellung von 2,2-Difluorbenzo[1.3]dioxolcarbaldehyden
NZ332762A (en) 1996-07-24 2000-09-29 Warner Lambert Co Isobutylgaba and its derivatives for the treatment of pain
GB9812413D0 (en) 1998-06-10 1998-08-05 Glaxo Group Ltd Compound and its use
FR2781793B1 (fr) 1998-08-03 2001-07-20 Prographarm Lab Procede de fabrication de granules de gabapentine enrobes
US6642398B2 (en) 1999-06-10 2003-11-04 Warner-Lambert Company Mono-and disubstituted 3-propyl gamma-aminobutyric acids
ME00921B (me) 2000-01-27 2012-06-20 Warner Lambert Co Asimetrična sinteza pregabalina
WO2001074741A2 (en) 2000-04-04 2001-10-11 Brandeis University Catalytic asymmetric desymmetrization of meso compounds
US6833458B2 (en) 2000-06-05 2004-12-21 Development Center For Biotechnology Practical syntheses of chiral trans-3, 4-disubstituted piperidines and the intermediates
DE10203122A1 (de) 2002-01-25 2003-07-31 Gruenenthal Gmbh Verfahren zur Herstellung von substituierten Acrylsäureestern bzw. deren Einsatz zur Herstellung von substituierten gamma-Aminosäuren
US20030225149A1 (en) 2002-04-30 2003-12-04 Blazecka Peter G. Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids
ATE371496T1 (de) 2004-03-12 2007-09-15 Warner Lambert Co C1-symmetrische bisphosphinliganden und deren verwendung bei der asymmetrischen synthese von pregabalin
EP1735324B1 (en) 2004-04-01 2008-08-20 Warner-Lambert Company LLC Preparation of p-chirogenic phospholanes and their use in asymetric synthesis
UA82292C2 (uk) 2004-04-14 2008-03-25 Пфайзер Продактс Инк. Спосіб стереоселективного біоперетворення аліфатичних динітрилів в ціанокарбонові кислоти (варіанти)
CN102102114B (zh) 2004-06-21 2013-08-14 沃尼尔·朗伯有限责任公司 普瑞巴林和相关化合物的制备
WO2006008640A1 (en) 2004-07-15 2006-01-26 Pharmacia & Upjohn Company Llc Non-aqueous suspension containing a drug having an unpleasant taste
CN1634869A (zh) 2004-12-06 2005-07-06 北京阜康仁生物制药科技有限公司 普瑞巴林新晶型及其制备方法
MX2007012606A (es) 2005-04-11 2008-01-11 Teva Pharma Proceso para elaborar (s)-pregabalina.
US7462737B2 (en) 2005-05-10 2008-12-09 Teva Pharmaceutical Industries Ltd. Pregabalin free of isobutylglutaric acid and a process for preparation thereof
CA2604602A1 (en) 2005-05-10 2006-11-16 Teva Pharmaceutical Industries Ltd. Method for the preparation of pregabalin and salts thereof
US20060270871A1 (en) 2005-05-30 2006-11-30 Khanduri Chandra H Polymorphic form i of pregabalin and processes for its preparation
CN100410242C (zh) 2005-06-23 2008-08-13 江苏恩华药业股份有限公司 普瑞巴林中间体及其制备方法
CZ297970B6 (cs) 2005-08-10 2007-05-09 Zentiva, A. S Zpusob výroby (S)-3-(aminomethyl)-5-methyl-hexanové kyseliny (pregabalinu)
CA2619472A1 (en) 2005-09-19 2007-03-29 Teva Pharmaceutical Industries Ltd. Chiral 3-carbamoylmethyl-5-methyl hexanoic acids, key intermediates for the new synthesis of (s)-pregabalin
TW200815323A (en) 2006-05-24 2008-04-01 Teva Pharma Processes for the preparation of R-(+)-3-(carbamoylmethyl)-5-methylhexanoic acid and salts thereof
EP2071032A3 (en) 2006-05-31 2009-07-08 Teva Pharmaceutical Industries Ltd The use of enzymatic resolution for the preparation of intermediates of pregabalin
ITMI20061297A1 (it) 2006-07-04 2008-01-05 Laboratorio Chimico Int Spa Procedimento per la preparazione della'acido (r)-(-)-3-(carbamoilmetil)-5-metilesanoico e del pregabalin e intermedi di sintesi
WO2008007145A2 (en) 2006-07-12 2008-01-17 Generics [Uk] Limited Process of preparing a gamma-amino acid
GB0614133D0 (en) 2006-07-15 2006-08-23 Pliva Istrazivanje I Razvoj D Process for preparing a pharmaceutical compound
US20080014280A1 (en) 2006-07-17 2008-01-17 Glenmark Pharmaceuticals Limited Amorphous pregabalin and process for the preparation thereof
KR101036536B1 (ko) 2007-03-22 2011-05-24 테바 파마슈티컬 인더스트리즈 리미티드 (ｓ)-(+)-3-(아미노메틸)-5-메틸 헥산산의 합성
EP1992609A1 (en) 2007-05-14 2008-11-19 Dipharma Francis S.r.l. A process for the preparation of a (S)(+)-3-(aminomethyl)-5-methylhexanoic acid
EP2017273A1 (en) 2007-07-18 2009-01-21 Laboratorios del Dr. Esteve S.A. Process for the enantioselective preparation of pregabalin
ITMI20072262A1 (it) 2007-12-03 2009-06-04 Dipharma Francis Srl Procedimento per la preparazione di acido (s)(+)-3-(amminometil)-5-metilesanoico

Also Published As

Publication number Publication date
WO2008118427A3 (en) 2008-12-18
CA2681313A1 (en) 2008-10-02
US8097754B2 (en) 2012-01-17
EP2021318A2 (en) 2009-02-11
WO2008118427A9 (en) 2009-02-05
KR101036536B1 (ko) 2011-05-24
TW200846308A (en) 2008-12-01
MX2008014759A (es) 2009-03-09
KR20090010075A (ko) 2009-01-28
US20080306292A1 (en) 2008-12-11
WO2008118427A2 (en) 2008-10-02
CA2681313C (en) 2012-09-11

Similar Documents

Publication Publication Date Title
BRPI0803092A2 (pt) sìntese de (s)-(+)-3-(aminometil)-5-metil ácido hexanóico, (s)-pregabalina
MA31831B1 (fr) Inhibiteurs de protéase époxy-cétone peptidique cristalline, et synthèse de céto-époxydes d'acides aminés
BR112014024157A2 (pt) Composição comestível, solução de estoque e método para complementar as características de sabor ou paladar de produtos comestíveis
GEP20146169B (en) N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
WO2009117987A3 (de) Verwendung von boswelliasäuren und synthetischen boswelliasäurederivaten zur hemmung der mikrosomalen prostaglandin e2 synthase und des cathepsin g
UA102817C2 (ru) Способ синтеза агомелатина
MX340125B (es) 2-hidroxi-4-(metiltio) butironitrilo estable en almacenamiento.
WO2008036967A3 (en) Novel heterocyclic compounds as lasy activators
BRPI0419067A (pt) método para aumento da cognição utilizando ziprasidona
WO2007127377A8 (en) Combinations comprising omega-3 fatty acid compounds for the treatment of cardiovascular disease
WO2008071928A3 (en) Corrosion inhibitor intensifier compositions and associated methods
MY148953A (en) Substituted biphenyl carboxylic acids and derivatives thereof
MA33069B1 (fr) Dérivés de thiadiazoles et d'oxadiazoles, leur préparation et leur application en thérapeutique
BR112013028486A2 (pt) método para promover crescimento de planta
UA107592C2 (uk) Композиція для боротьби з захворюваннями рослин і її застосування
EA200701810A1 (ru) Производное изоксазолина и новый способ его получения
EA200600878A1 (ru) Производные феноксиуксусных кислот, применимые в качестве двойных агонистов активируемого пероксисомным пролифератором рецептора ( ppar )
MY137277A (en) Pharmaceutically useful salts of carboxylic acid derivates
BRPI0607093A2 (pt) polimorfo cristalino de monoidrato de sal monossódico de ácido 3-(n-metil-n-pentil)amino-1-hidroxipropano-1, 1-difosfÈnico, ibandronato, processo para a preparação de um polimorfo de ibandronato cristalino, e composição farmacêutica que o compreende
CY1111730T1 (el) Διαδικασια για την παρασκευη γκαμπαπεντινης
BR112012006397A2 (pt) composição de inibidor de corrosão, e, método.
BR0300673A (pt) Método para aprimorar o clareamento da pele
BRPI0814115B8 (pt) composição farmacêutica compreendendo o composto 11-deóxi-prostaglandina e método para estabilizar o composto
DE602006008962D1 (de) Verfahren zur herstellung von valsartan
MX2010006995A (es) 3-n-fenil-1,3,4-oxadiazolonas sustituidas con 5-o para uso medico.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2162 12/06/2012.